Literature DB >> 832652

Comparative evaluation of intravenous phenytoin, procainamide and practolol in the acute treatment of ventricular arrhythmias.

E Karlsson, A Kinman, C Sonnhag.   

Abstract

Ten patients with a persistent ventricular arrhythmia, but no other sign of heart disease, were studied by means of an exercise test performed 4 times with a fixed work load, over 30--40 min. No drug was given in the first exercise test and in the others phenytoin, procainamide or practolol were chosen at random for i.v. administration. Blood samples for determination of plasma concentration were frequently collected. The ECG was recorded continuously during the exercise test and was analysed minute by minute. Despite plasma levels within the suggested therapeutic range, only procainamide showed a statistically significant antiarrhythmic effect in this group of patients.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 832652     DOI: 10.1007/BF00561779

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  19 in total

1.  Relationship of premature systoles to coronary heart disease and sudden death in the Tecumseh epidemiologic study.

Authors:  B N Chiang; L V Perlman; L D Ostrander; F H Epstein
Journal:  Ann Intern Med       Date:  1969-06       Impact factor: 25.391

2.  Plasma concentration of procainamide and prevalence of exertional arrhythmias.

Authors:  G O Gey; R H Levy; L Fisher; G Pettet; R A Bruce
Journal:  Ann Intern Med       Date:  1974-06       Impact factor: 25.391

3.  Antiarrhythmic prophylaxis with procainamide in acute myocardial infarction.

Authors:  J Koch-Weser; S W Klein; L L Foo-Canto; J A Kastor; R W DeSanctis
Journal:  N Engl J Med       Date:  1969-12-04       Impact factor: 91.245

Review 4.  The current status of diphenylhydantoin in heart disease.

Authors:  E N Mercer; J A Osborne
Journal:  Ann Intern Med       Date:  1967-11       Impact factor: 25.391

5.  Relationship between ventricular premature contractions on routine electrocardiography and subsequent sudden death from coronary heart disease.

Authors:  F D Fisher; H A Tyroler
Journal:  Circulation       Date:  1973-04       Impact factor: 29.690

6.  Micromethod for the determination of diphenylhydantoin in plasma and cerebrospinal fluid--a comparison between a gas chromatographic and a spectrophotometric method.

Authors:  A Berlin; S Agurell; O Borgå; L Lund; F Sjöqvist
Journal:  Scand J Clin Lab Invest       Date:  1972-05       Impact factor: 1.713

7.  Occurrence of ventricular arrhythmias with exercise as compared to monitoring.

Authors:  B D Kosowsky; B Lown; R Whiting; T Guiney
Journal:  Circulation       Date:  1971-11       Impact factor: 29.690

8.  Procainamide dosage schedules, plasma concentrations, and clinical effects.

Authors:  J Koch-Weser; S W Klein
Journal:  JAMA       Date:  1971-03-01       Impact factor: 56.272

9.  A method for estimation of plasma diphenylhydantoin concentration.

Authors:  J T Bigger; D H Schmidt; H Kutt
Journal:  Am Heart J       Date:  1969-04       Impact factor: 4.749

10.  Intermittent intravenous procaine amide to treat ventricular arrhythmias. Correlation of plasma concentration with effect on arrhythmia, electrocardiogram, and blood pressure.

Authors:  E G Giardina; R H Heissenbuttel; J T Bigger
Journal:  Ann Intern Med       Date:  1973-02       Impact factor: 25.391

View more
  4 in total

1.  Serum procainamide levels as therapeutic guides.

Authors:  J Koch-Weser
Journal:  Clin Pharmacokinet       Date:  1977 Nov-Dec       Impact factor: 6.447

2.  Efficacy and tolerance of tocainide during acute and long-term treatment of chronic ventricular arrhythmias.

Authors:  C Sonnhag
Journal:  Eur J Clin Pharmacol       Date:  1980-10       Impact factor: 2.953

3.  Comparative antiarrhythmic efficacy of intravenous N-acetylprocainamide and procainamide.

Authors:  C Sonnhag; E Karlsson
Journal:  Eur J Clin Pharmacol       Date:  1979-06-12       Impact factor: 2.953

4.  Pharmacokinetic approach to intravenous procainamide therapy.

Authors:  J J Lima; D R Conti; A L Goldfarb; L H Golden; W J Jusko
Journal:  Eur J Clin Pharmacol       Date:  1978-06-19       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.